vs
Lifeward Ltd.（LFWD）与波士顿科学（MLSS）财务数据对比。点击上方公司名可切换其他公司
波士顿科学的季度营收约是Lifeward Ltd.的10.3倍（$2.1M vs $200.0K），波士顿科学净利率更高（-53.0% vs -2674.0%，领先2621.0%），Lifeward Ltd.同比增速更快（100.0% vs 2.2%），过去两年波士顿科学的营收复合增速更高（-4.3% vs -36.0%）
波士顿科学公司是源自美国的跨国生物医疗企业，专业研发生产介入医疗领域医疗器械，产品覆盖介入放射学、介入心脏病学、外周介入治疗、神经调控、神经血管介入、电生理、心脏外科、血管外科、内镜、肿瘤学、泌尿与妇科等多个领域。
LFWD vs MLSS — 直观对比
营收规模更大
MLSS
是对方的10.3倍
$200.0K
营收增速更快
LFWD
高出97.8%
2.2%
净利率更高
MLSS
高出2621.0%
-2674.0%
两年增速更快
MLSS
近两年复合增速
-36.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $200.0K | $2.1M |
| 净利润 | $-5.3M | $-1.1M |
| 毛利率 | — | 73.0% |
| 营业利润率 | -2559.0% | -52.5% |
| 净利率 | -2674.0% | -53.0% |
| 营收同比 | 100.0% | 2.2% |
| 净利润同比 | 65.0% | 46.4% |
| 每股收益（稀释后） | $-15.92 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFWDMLSS
| Q4 25 | $200.0K | $2.1M | ||
| Q3 25 | $300.0K | $2.4M | ||
| Q2 25 | $400.0K | $2.3M | ||
| Q1 25 | $500.0K | $2.2M | ||
| Q4 24 | $100.0K | $2.0M | ||
| Q3 24 | $612.0K | $2.5M | ||
| Q2 24 | $499.0K | $1.9M | ||
| Q1 24 | $489.0K | $2.2M |
净利润LFWDMLSS
| Q4 25 | $-5.3M | $-1.1M | ||
| Q3 25 | $-3.2M | $-1.2M | ||
| Q2 25 | $-6.6M | $-1.5M | ||
| Q1 25 | $-4.8M | $-2.0M | ||
| Q4 24 | $-15.3M | $-2.0M | ||
| Q3 24 | $-3.1M | $-1.5M | ||
| Q2 24 | $-4.3M | $223.6K | ||
| Q1 24 | $-6.3M | $-1.4M |
毛利率LFWDMLSS
| Q4 25 | — | 73.0% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 69.6% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | 75.0% | ||
| Q3 24 | — | 73.0% | ||
| Q2 24 | — | 76.1% | ||
| Q1 24 | — | 74.5% |
营业利润率LFWDMLSS
| Q4 25 | -2559.0% | -52.5% | ||
| Q3 25 | -1046.7% | -48.1% | ||
| Q2 25 | -1640.8% | -63.9% | ||
| Q1 25 | -970.6% | -89.5% | ||
| Q4 24 | -15228.0% | -101.4% | ||
| Q3 24 | -518.6% | -58.4% | ||
| Q2 24 | -890.4% | -96.0% | ||
| Q1 24 | -1329.7% | -65.1% |
净利率LFWDMLSS
| Q4 25 | -2674.0% | -53.0% | ||
| Q3 25 | -1056.7% | -48.9% | ||
| Q2 25 | -1640.5% | -63.8% | ||
| Q1 25 | -966.8% | -89.3% | ||
| Q4 24 | -15278.0% | -101.1% | ||
| Q3 24 | -503.9% | -58.1% | ||
| Q2 24 | -862.5% | 12.1% | ||
| Q1 24 | -1283.4% | -64.1% |
每股收益（稀释后）LFWDMLSS
| Q4 25 | $-15.92 | — | ||
| Q3 25 | $-0.20 | $-0.01 | ||
| Q2 25 | $-0.58 | — | ||
| Q1 25 | $-0.46 | — | ||
| Q4 24 | $-38.38 | — | ||
| Q3 24 | $-0.35 | $-0.02 | ||
| Q2 24 | $-0.50 | — | ||
| Q1 24 | $-0.73 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.2M | $1.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $8.4M | $2.8M |
| 总资产 | $22.9M | $7.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LFWDMLSS
| Q4 25 | $2.2M | $1.1M | ||
| Q3 25 | $2.0M | $1.3M | ||
| Q2 25 | $5.1M | $1.3M | ||
| Q1 25 | $5.7M | $2.2M | ||
| Q4 24 | $6.7M | $3.3M | ||
| Q3 24 | $10.7M | $4.8M | ||
| Q2 24 | $15.1M | $5.8M | ||
| Q1 24 | $20.7M | $5.0M |
股东权益LFWDMLSS
| Q4 25 | $8.4M | $2.8M | ||
| Q3 25 | $12.8M | $2.5M | ||
| Q2 25 | $15.1M | $3.3M | ||
| Q1 25 | $18.5M | $4.5M | ||
| Q4 24 | $18.8M | $5.8M | ||
| Q3 24 | $33.9M | $7.2M | ||
| Q2 24 | $36.7M | $8.0M | ||
| Q1 24 | $40.6M | $7.5M |
总资产LFWDMLSS
| Q4 25 | $22.9M | $7.8M | ||
| Q3 25 | $23.2M | $8.5M | ||
| Q2 25 | $26.8M | $8.1M | ||
| Q1 25 | $28.8M | $9.1M | ||
| Q4 24 | $30.5M | $9.8M | ||
| Q3 24 | $45.8M | $11.2M | ||
| Q2 24 | $51.0M | $12.0M | ||
| Q1 24 | $55.2M | $11.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.6M | $-226.1K |
| 自由现金流经营现金流 - 资本支出 | $-3.6M | — |
| 自由现金流率自由现金流/营收 | -1783.0% | — |
| 资本支出强度资本支出/营收 | 5.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LFWDMLSS
| Q4 25 | $-3.6M | $-226.1K | ||
| Q3 25 | $-3.8M | $81.8K | ||
| Q2 25 | $-3.9M | $-1.8M | ||
| Q1 25 | $-5.5M | $-1.0M | ||
| Q4 24 | $-4.0M | $-1.5M | ||
| Q3 24 | $-4.5M | $-973.9K | ||
| Q2 24 | $-5.6M | $783.7K | ||
| Q1 24 | $-7.7M | $-1.2M |
自由现金流LFWDMLSS
| Q4 25 | $-3.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-5.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率LFWDMLSS
| Q4 25 | -1783.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -1099.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度LFWDMLSS
| Q4 25 | 5.5% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率LFWDMLSS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.50× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
